Orquillas, Baby Boy .

HRN: 26-58-22  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2025
AMPICILLIN 1GM (VIAL)
02/11/2025
02/17/2025
IV
160mg
Q12
PNSB
Waiting Final Action 
02/11/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/11/2025
02/17/2025
IV
30 Mg
Q24
PNSB
Waiting Final Action 
02/11/2025
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
02/11/2025
02/11/2025
TOPICAL OPHTHALMIC OINTMENT
0.5%
Once
Eye Prophylaxis
Waiting Final Action 
02/13/2025
CEFOTAXIME 500MG (VIAL)
02/13/2025
02/19/2025
IVT
160mg
Q12
Neonatal Pneumonia
Waiting Final Action 
02/13/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/13/2025
02/19/2025
IVT
24mg
Q12
Neonatal Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: